Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: A mechanism for gonadotrophin releasing hormone agonist-induced tumour regression

Molecular Human Reproduction

Volumn 3, Issue 11, 1997, Pages 1005-1014

  Dou, Qingchuan ^a   Tarnuzzer, Roy W ^a   Williams, R Stan ^a   Schultz, Gregory S ^a   Chegini, Nasser ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

GnRH agonis; Leiomyoma; Metalloproteinases; Myometrium; TIMPs

Indexed keywords

GONADORELIN; MESSENGER RNA; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; BIOSYNTHESIS; CELL DIVISION; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; UTERUS CANCER;

ADULT; CELL DIVISION; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; METALLOENDOPEPTIDASES; MIDDLE AGED; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UTERINE NEOPLASMS;

EID: 0031262089     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/3.11.1005     Document Type: Article

References (41)

1. Aston, K E., Staraouli, A., Thomas, E.J. et al. (1996) Effect of gonadotrophin on cell and matrix retention and expression of metalloprotemases and their inhibitor in cultured human granulosa cells modelling corpus luteum function. Mol. Hum. Reprod., 2, 26-30.
2. Border, W.A. and Noble, N.A. (1994) Transforming growth factor β in tissue fibrosis. New Eng. J. Med., 331, 1286-1292.
3. Branden, D.D., Bethea, C.L., Strawn, E.Y. et al. (1993) Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas Am. J. Obstet. Gynecol., 169, 78-85.
4. Bruner, K., Rodgers, W.H., Gold, L.I. et al. (1995) Transforming growth factor β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc. Natl. Acad. Sci. USA, 95, 7362-7366
5. Bulum, S.E., Simpson, E.R. and Word, R.A (1994) Expression of the CYP19 gene and its products aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. J. Clin. Endocrinol. Metab., 78, 736-743.
6. Carr, B.R., Marshburn, P.B., Weatherall, P.T. et al. (1993) An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial. J Clin. Endocrinol. Metab., 76, 1217-1223.
7. Chegini, N. (1997) Implication of growth factors and cytokines network in uterine leiomyoma. In Hill, J.A. (ed.), Cytokines in Reproduction. Medical Intelligence Series. Landes Bioscience, Georgetown, TX, USA (in press).
8. l25I-TGF-β1 binding sites. Endocrinology, 135, 439-449.
9. Chegini, N., Rong, H., Dou, Q. et al. (1996) Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro. J. Clin. Endocrinol. Metabol., 81, 3215-3221.
10. Chrapusta, S., Sieinski, W., Konopka, B. et al. (1990) Estrogen and progestin receptor levels in uterine leiomyomata: relation 10 the tumor histology and the phase of menstrual cycle. Eur. J. Gynecol Oncol., 11, 381-387.
11. Dou, Q., Zhao, Y., Tarmizzer, R.W. et al. (1996) Suppression of TGF-βs and TGH-β receptors mRNA and protein expression in leiomyomata in women receiving gonadotropin releasing hormone agonist therapy. J. Clin. Endocrinol. Metabol., 81, 3222-3230.
12. Hulboy D.L., Rudolph L.A. and Matrisian, L.M (1997) Matrix metalloproteinases as mediators of reproductive function. Mol. Hum. Reprod., 3, 27-45.
13. Gutmann, J.N., Thronton, K.L. Diamond, M.P. et al (1994) Evaluation of leuprolide acetate treatment on histopathology of uterine myomata. Fertil. Steril, 61, 622-626.
14. Kawaguchi, K., Fuji, S., Konishi, I. et al. (1989) Mitotic activity in uterine leiomyomas during the menstrual cycle. Am. J. Obstet. Gynecol., 160, 637-641.
15. Lemay, A. and Maheux, R. (1996) GnRH agonists in the management of uterine leiomyoma. Infertil. Reprod. Med. Clin. North Am., 7, 33-55.
16. Marbaix, E., Donnez, J., Courtoy, PJ. et al. (1992) Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc. Natl. Acad. Sci. USA, 89, 11789-11793.
17. Marbaix, E., Kokorine, I., Donnez, J. et al. (1996) Regulation and restricted expression of interstitial collagenase suggest a pivotal role in the initiation of menstruation. Hum. Reprod., 11 (Suppl. 2), 134-143.
18. Martelli, M., Campana, A. and Bishoff, P. (1993) Secretion of matrix J metalloproteinases by human endometrial cells in vitro. J. Reprod. Fertil., 98, 67-76.
19. Matrisian, L.M. (1992) The matrix-degrading metalloproteinases. Bioassay, 14, 455-463.
20. Matnsian, L.M. (1994) Matrix metalloproteinases gene expression. Ann. NY Acad. Sci., 732, 42-50.
21. Mosher, D.E. Sottile, J., Wu, C. et al. (1992). Assembly of extracellular matrix. Curr. Opin. Cell Biol., 4, 810-818.
22. Murphy, A.A , Morales, A.J., Kettel, L.M. et al. (1995) Regression of uterine leiomyomata to the antiprogesterone RU486: Dose-response effect. Fertil. Steril., 64, 187-190.
23. Nardelli, G.B., Mega, M., Bertasi, M. et al. (1987) Estradiol and progesterone binding in uterine letomyomata and pregnant myometrium. Clin. Exp. Obstet. Gynecol, 14, 155-160.
24. Osteen, K.G., Rodgers, W.H., Gaire, M. et al. (1994) Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc. Natl. Acad. Sci. USA, 91, 10129-10133.
25. Overall, C.M. (1994) Regulation of tissue inhibitor of matrix metalloproteinases expression. Ann. NY Acad. Sci., 732, 51-64
26. Puistola, U., Ristili, L., Ristili, J. et al. (1990) Collage metabolism in gynecologic patients: changes in the concentration of the aminoterminal propeptide of type III procollagen in serum. Am. J. Obstet. Gynecol., 163, 1276-1281.
27. Rein, M.S., Barbien, R.L. and Friedman, A.J. (1995) Progesterone: a critical role in the pathogenesis of uterine myomas. Am. J. Obstet. Gynecol., 172, 14-18.
28. Remsch, R.C., Murphy, A.A., Morales. A.J et al. (1994) The effects of RU486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: A prospective, randomized study. Am. J. Obstet Gynecol., 170, 1623-1628.
29. Rodgers, W.H., Osteen, K.G., Matrisian, L.M. et al. (1993) Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am. J. Obstet. Gynecol., 168, 253-260.
30. Rodgers, W.H., Matrisian, L., Giudice, L.C. et al. (1994) Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J. Clin. Invest., 94, 946-953
31. Salamonsen, L.A. and Wooley, D.E (1996) Matrix metalloproteinases in normal menstruation. Hum. Reprod., 11 (Suppl. 2), 124-133.
32. Sato, T., Ito, A., Mon, Y. et al. (1991) Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Biochem. J., 275, 645-650.
33. Schatz, F., Papp, C. Totth-Pal, E. et al. (1994) Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells, J. Clin. Endocrinol. Metabol., 78, 1467-1472.
34. Stewart, E.A., Friedman, A.J., Peck, K. et al. (1994) Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. J. Clin. Endocrinol. Metab., 79, 900-906.
35. Sullivan, M.W. and Guzick, D S (1996) The natural history of utenne myomas. Inferül Reprod. Med. Clin. North Am., 7, 1-4.
36. Tang, X-M., Ghahary, A. and Chegini, N. (1996) The interaction between transforming growth factor β and relaxin leads to modulation of matrix metalloproteinases expression in human uterus. J. Soc. Gynecol. Invest., 3, Abstr. #205.
37. Tang, X. M., Dou, Q., Zhao, Y. et al (1997) The expression of transforming growth factor-βs and TGF-β receptor mRNA and protein and the effect of TGF-βs on human myometrial smooth muscle cells in vitro. Mol. Hum. Reprod., 3, 233-240.
38. Tarnuzzer, R.W., Macauley, S.P., Farmerie, W.O. et al. (1996) Competitive RNA templates for detection and quantification of growth factors, cytokines, extracellular matrix components and matrix metalloproteinases by RT-PCR. BioTechniques. 20, 670-674.
39. Upadhyaya, N.B., Doody, M.C. and Googe, P.B. (1990) Histological changes in letomyomata treated with leuprolide acetate. Fertil. Steril., 54, 811-814
40. Waterhouse, P., Denhardt, D.T. and Khokha, R. (1993) Temporal expression of tissue inhibitors of metalloproteinases in mouse reproductive tissues during gestation. Mol. Reprod. Dev., 35, 219-226.
41. Woessner, J.F., Jr. (1994) The family of matrix metalloproteinases. Ann. NY Acad. Sci., 732, 11-21.